Astrocytes have been recognized as important elements in controlling inflammatory as well as immune processes in the central nervous system (CNS). Recently, glial cells have been shown to produce cysteinyl leukotrienes (CysLTs) which are known lipid mediators of inflammation and whose extracellular concentrations rise under different pathological conditions in the brain. In the same conditions also extracellular concentrations of ATP dramatically increase reaching levels able to activate P2X 7 ionotropic receptors for which an emerging role in neuroinflammation and neurodegeneration has been claimed. RT-PCR analysis showed that primary cultures of rat brain astrocytes express P2X 7 receptors. Application of the selective P2X7 agonist benzoyl-benzolyATP(BzATP) markedly increased [Ca"], which was mediated by a calcium influx from the extracellular milieu. The P2X 7 antagonist, oATP,suppressed the BzATP-induced calcium increase. Consistent with the evidence that increased calcium levels activate the leukotriene biosynthetic pathway, challenge of astrocytes with either the calcium ionophore A23187 or BzATP significantly increased CysLT production and the cell pre-treatment with EGTA abolished these effects. Again the P2X7 antagonist prevented the BzATP-mediated CysLT efflux, whereas the astrocyte pretreatment with MK-571, a CysLT I receptor antagonist, was ineffective. The astrocyte pre-treatment with a cocktail of inhibitors of ATP binding cassette (ABC) proteins reduced the BzATP-mediated CysLT production confirming that ABC transporters are involved in the release of CysLTs. The astrocyte P2X 7evoked rise of CysLT efflux was abolished in the presence of MK-886, an inhibitor of 5-lipoxygenase activating protein (FLAP) whose expression, along with that of 5'-lipoxygenase (5-LO) was reported by Northern Blot analysis. The stimulation ofP2X 7 induced an up-regulation of FLAP mRNA that was reduced by the antagonist oATP. These data suggest that in rat brain cultured astrocytes P2X 7 ATP receptors may participate in the control of CysLT release thus further supporting a role for extracellular ATP as an integral component of the inflammatory brain response.
inflammatory agents associated with these pathological processes, such as cytokines, proteases and protease inhibitors (30, 22, 53) .
Amongst glia, astrocytes play an important role in inflammatory, as well as in immune processes in the central nervous system (CNS) (17, 16) . In response to a variety of insults to the central nervous system (CNS), astrocytes become "reactive", changing shape, dividing, releasing various trophic factors and contributing to glial scar (11, 43) . Particularly, astrocytes release a significant amount of adeninebased nucleotides under physiological and even more under pathological conditions (18, 13) . Previous studies showed that high concentration of extracellular ATP have been observed at sites of tissue trauma (37) . In addition to its well-known role as a neurotransmitter, ATP is able to regulate immune and inflammatory responses via activation ofP2Y Gprotein-coupled receptors (8) and P2X ligand gated ion channels (27) .
Among these receptor superfamilies, the P2X 7 receptors, mainly expressed in immune cells, have been reported to play a prominent role in immunomodulation and inflammation by regulating the secretion of several pro-inflammatory agents. In the peripheral nervous system, ATP-activation of P2X 7 induced the maturation and release of IL-ll3 by LPS-challenged Schwann cells (15) . In microglia and astrocytes, the expression of P2X 7 receptors has been reported and pharmacological and/or functional evidences suggest that they may exert an important role in mediating nucleotide responses in either normal or injured brain (23, 6) .
In microglia the signal transduction pathways linked to the activation ofP2X 7 ATP receptor, as well as its role in the modulation of cytokine release, seem to be better defined. Furthermore, microglia stimulated by either ATP or Benzoyl-ATP (BzATP), an agonist of P2X 7 receptors, have neurotoxic properties (39) , indicating that the P2X 7-mediated events could contribute to neurodegeneration. This hypothesis fits well with the recent evidence that P2X 7 receptor is specifically up-regulated around beta-amyloid plaques in a mouse model of Alzheimer's disease (39) .
Much less is known about the P2X 7-mediated effects in astroglial cells. Previously we reported that in cultured astrocytes from rat brains BzATP, the most potent P2X 7 receptor agonist, induced an increase of adenine-based purine release and triggered a sustained and dose-dependent increase of intracellular calcium concentration. These effects were abolished by cell pre-treatment with the P2X 7 receptor antagonist oATP (6) . Moreover, P2X 7 activation in astrocytes has been reported to increase the expression of MCP-l, a chemokine which is upregulated after CNS trauma (38) .
Another group of pro-inflammatory agents, the cysteinyl leukotrienes, (CysLTs), namely LTC4' LTD4 and LTE4' playa role in diverse pathological processes in brain, including seizures, hemorrhage, ischemia and tumors (50, 14, 51, 49) . CysLTs are members of a large family of molecules known as eicosanoids whose biosynthesis is triggered by the action of cytosolic phospholipase A2 followed by the action of 5-lipoxygenase and 5-lipoxygenase activating protein (FLAP) on arachidonic acid (9) . Several inflammatory cells including mast cells, macrophages and eosinophils, produce and release CysLTs under different kinds of stimuli. The cellular sources of these substances, along with their role in the CNS are still largely unknown. Recently we reported (12,3) that astrocytes and microglia release CysLTsboth under resting conditions and, even more so, after stimulation, and that these glial cells express both CysLT1 and CysLT2 receptor subtypes (12) .
In this study we investigated the expression and function of P2X 7 receptors in primary cultures of rat astrocytes. We are particularly interested in exploring potential novel targets that might permit pharmacological modulation of brain inflammation. To that end we investigated the effects of P2X 7 activation on the biosynthetic release of CysLTS from rat astrocytes in culture.
MATERIALS AND METHODS

Materials
A23187, 2'-3'-0-(4 Benzoylbenzoyl) adenosine 5' triphosphate trithylammonium salt (BzATP), oxidized ATP (oATP), probenecid, sulfinpyrazone, ethylene glycol-bis(f3aminoethyl ether)-N,N,N' ,N' ,-tetraacetic acid (EGTA) and poly-D-lysine, were from Sigma (Sigma-Aldrich, Milan, Italy), {1-[2-(5-Carboxyoxazol-2yl)-6aminobenzofuran-5oxy]-2(2' -amino-5' -methyl phenoxy)-ethane-,N,N'N'tetraacetic Acid Pentaacetoxymethyl Ester} (fura-2/AM) was purchased from Calbiochem (Calbiochem-Novabiochem Corp., CA, USA), [(+)-3-(((3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3 -(dimethylamino)-3oxopropyl)thio)methyl)thio) propanoic acid] (MK-571) and CysLT enzyme immunoassay (EIA) kit and were purchased from Cayman Chemicals (Ann Arbor, MI, USA), 
Rat cortical astrocytes
Primary cultures of astrocytes were prepared according to Levison and McCarthy (1991) (32) with slight modification. Two-four days old postnatal rats were used. After decapitation, neocortices were collected in the usual growth medium (high glucose DMEM supplemented with 10% FBS). Subsequently, the tissue was washed in phosphate buffered saline (PBS), cut in small fragments and digested with 0.025% trypsin/O.04% EDTA solution in PBS for 20 min at 37°C and then dissociated in 0.01 % DNAse solution in growth medium for 10 min at 37°C. The cell suspension obtained was centrifuged at 1300 rpm for 10 min and the pellet was resuspended in growth medium, also containing 5 mM Lleucine methyl ester in order to restrain microglia contamination. Cells were seeded onto poly-D-lysine (10 ug/ml) coated flasks and maintained at 37°C in a humidified incubator under 95% air and 5% CO 2 , After the first 24 h, culture medium was renewed with an identical medium without leucine methyl ester and it was then replaced every 3-4 days. At the 7 th and then at the 13 th day in vitro (DIV), the cells were shaken for 3 h at 80 rpm on a plate shaker to minimise microglia contamination. For bioassays, confluent primary cultures of astrocytes at the 14 th DIV were trypsinized (0.025% trypsin/O.04% EDTA dissolved in PBS, 10-20 min, 37°C) and re-plated at a concentration of about 20-25 x 10 3 cells/em'. After seeding, cells were maintained in the usual medium containing 5 mM leucine methyl ester only for the first 24 h.
Measurement ofcysteinylleukotriene ejJlux
To measure CysLT efflux, microglial cultures were rinsed twice and then incubated with Krebs solution (700 Ill) containing (in millimolar units): 118.5 NaCl, 4.7 KCl, 2.5 CaC1 2 , 1.2 MgS0 4 , 1.2 KH 2P04 , 25 NaHC0 3 , 10 glucose (pH adjusted to 7.3-7.4). After a stabilisation period of60 min in standard conditions (37°C, humidified incubator, 95% air/5% C02), primary microglial cultures were challenged for 30 min with A23187 or BzATP. At the end of the stimulation period, the cultures returned to standard conditions (fresh Krebs solution) for further 60 min. When cell-pre-treatments were performed, MK-886, an inhibitor of leukotriene synthesis, or MK-571, an antagonist for CysLT1 receptors, were added 30 min before stimulation whereas probenecid, an inhibitor of the ATP binding cassette protein MRP 1 was added 60 min prior to cell exposure to BzATP,EGTA was added 15 min before stimulation with the ATP analogue and oATP, the P2X 7 receptor antagonist was added 2 hours before astrocyte challenge with BzATP. All these drugs were maintained up to the end of the experiments. Aliquots of supernatant (100 ul) were collected every 30 min and stored at -80°C until tested. The samples were then assayed by a commercial EIA kit, according to the manufacturer's instructions. The antibody contained in this kit had specificity of 100% towards LTC4 and LTD4 and of about 70% towards LTE4' thus allowing us to measure the principal CysLTs. The same antibody displayed a negligible interaction with prostanoids and fatty acids «0.01 %). The detection limit was 10-15 pg/ml.
RNA extraction
Total RNA was isolated from confluent rat cultured astrocytes using TRIzol reagent according to the manufacturer's recommendations. The resulting RNA pellet was washed with 70% ice-cold ethanol, air-dried and re-dissolved in 30 III diethyl-pyrocarbonate (DEPC)treated water. The quantity and purity of RNA were estimated spectrophotometrically by absorbance at 260 nm, and 5 ug were run on formaldehyde gel to confirm the integrity of the RNA, as indicated by the preservation of the 28 and 18S rRNA.
RT-PCR analysis for P2X 7ATP receptor, 5-lipoxygenase (5-LO) and 5-lipoxygenase activating protein (FLAP)
To remove any genomic DNA contaminants, RNA samples (10 ug) were treated with 1 unit DNase-I, RNasefree. First strand cDNA was synthesised from 1.5 ug of total RNA using the RT-PCR system RETROscript™ with random hexamers. The sequences of the primers for amplification of P2X 7 , 5-lipoxygenase (5-LO) and 5lipoxygenase activating protein (FLAP) receptor genes were the following: forward 5'-GTTTTGACATC CTGGTTTTTG-3' and reverse 5'-CTGCGGTTCTCTGGTAGTTGA-3' for P2X 7 (GenBank accession number X95882), forward 5'-AAAGAACTGGAA ACAGCTCAGAAA-3' and reverse 5'-AACTGGTGTGTACAGGGGTCAGTT-3' for rat 5lipoxygenase (Genbank, accession number NM_012822); forward 5'-CTGAGCAAGCATGGATCAAGA-3' and reverse 5'-GGGAGATCGTCGTGGTTATAGTTC-3' for rat 5-lipoxygenase activating protein (FLAP) (Genbank, accession number X52196). The cDNA (2 ug) was amplified in 100 III containing PCR reaction buffer, MgCl2 (1.5 mM), deoxy-dNTPs (0.2 mM each), oligonucleotide primers (1IlM), 2.5 U AmpliTaqGold™ DNA polymerase. Conditions applied for PCR reaction were: 94°C for 5 min, 35 cycles of denaturation at 94°C for 1 min, annealing at 56°C for 1 min and elongation at 72°C for 1 min. The final elongation was carried out for 10 min at 72°C. Reaction was also conducted without the reverse transcriptase step as control for genomic contamination. Amplification products were resolved by agarose (1.5%) gel electrophoresis. The identity of the products was confirmed by cycle sequencing the amplified cDNA.
Northern blot assay of 5-lipoxygenase (5-LO) and 5lipoxygenase activating protein (FLAP)
For RNA determination, astrocytes in 100-mm dishes were incubated for 24h in a medium containing 1% FBS to synchronize the cells and then treated with 100 IlM BzATP for 30 min.
Total RNA was isolated from the cells as reported above. Equal amounts of RNA (15 ug/lane) were fractionated on formaldehyde denaturing 1% agarose gel and blotted overnight onto Hybond N nylon membrane. The filter was then UV cross-linker in UV Stratalinker 1800 (Stratagene). The blots were prehybridized at least 8 hours at 42°in a solution containing 50% formammide, 5x Denhardt's Solution, 0,1% SDS and 100 ug/ml salmon sperm DNA. Hybridization of cDNA probes was performed in a buffer of the same composition containing 10 6 cpmlml of radiolabelled probe. cDNAs, obtained by extracting PCR products from agarose gel slices were radiolabelled by the method of random priming (Megaprime DNA labelling system) using [32 p]-dCTP. After hybridization, the membranes were washed in O.lX SSC containing 0.1% SDS at 50°C and exposed to Kodak Biomax MS autoradiography film at -80°C with intensifying screen for 2 days. Subsequent to hybridization with 5-LO or FLAP cDNA probe, Northern blots were hybridized with a probe for GAPDH to allow correction for the recovery of RNA in each sample. Experiments were performed in triplicate. For the purpose of quantification, autoradiograms were scanned using laser densitometry. FLAP or 5-10 mRNA signals were normalized against GAPDH content by determining of the ratio of the respective optical densities.
Intracellular calcium measurements Intracellular calcium concentration ([Ca 2+h) was
measured with the fluorescent indicator Fura-2 as described previously (6) . In brief, cultures were washed twice with phosphate-buffered saline and cells were detached from the flasks with a 0.025% trypsin-EDTA solution (37°C, 5 min). Cells were then washed twice by centrifugation in a standard buffer containing 125 mM NaCl Measurement ofFura-2 e.fJlux. Astrocytes were loaded with Fura-2 (20 IlM) as described above. Two milliliters of the cell suspension were incubated at 37°C in the absence (controls) and in the presence of BzATP (100 or 300 IlM). At the chosen times the cells were pelletted by centrifugation for 2 min and the supernatants were collected for measurements of fura 2 released from the cells. Each value is expressed as the percentage of the value measured following cell penneabilization with 0,03 % saponin.
Data Analysis
The statistical significance was established analysing data by ANOVA followed by Dunnett's multicomparison test or by Student's two-tailed t-test, using Prism (version 3.03) program (GraphPad Software, San Diego, CA, USA)
RESULTS
RT-PCR det ection ofP2X 7ATP receptor g ene in rat brain astrocytes
Expression of P2X 7 ATP receptors in rat brain cultured astrocytes was determined at the RNA level by RT-PCR analysis (Fig. 1) . Oligonucleotide primer pairs targeted to the COOH-terminal of the P2X 7 receptor were synthesized. The PCR product was separated on a 1.5 % agarose gel and a single band of 529 bp was detected, which corresponded to P2X 7 receptor mRNA. The identity of the fragment was confirmed by direct sequencing of the PCR product, which showed 95 % homology with the published sequence of the rat P2X 7 receptor (data not shown).
Effect of P2X 7 ac tivation on rat brain astrocyte intra cellular calcium levels
BzATP, a potent P2X 7 agonist (20) triggered a ' 1 700 bp 500 bp + rapid and sustained rise of [Ca"], as shown in Fig. 2A .
The maximal concentration of BzATP used did not exceed 100 u M because higher concentrations of the nucleotide quenched the fluorescence of Fura-2 used to measure [Ca"]! (21). BzATP is more potent than the naturally occurring agonist, ATP. Accordingly, addition of 2mM ATP to the astrocyte suspension, caused a rise in [Ca"], similar to that mediated by BzATP 100 /--lM ( Fig 2B) . When astrocytes were preincubated for 2 hours in the presence of 300 u M oATP, an irreversible and selective antagonist of P2X 7 receptor sites (36) , the increases of [Ca 2 +h induced by either 100 u M BzATP or 2mM ATP were significantly reduced -by about 77% and 50% respectively ( Fig.2A and B lower tracings) . Previous data showed that the BzATP-evoked Ca 2 +response in rat brain astrocytes was completely abolished by removal of external Ca 2 + (6). Neither cell pretreatment with the protein kinase C (PKC) activator 4p-phorbol 12-myristate 13-acetate (PMA) (1 u M for 30 min) , to inhibit the IP3-induced release of intracellular calcium (33) , nor challenging the cells with the sequisterpene lactone tumor promoter thapsigargin (Tg) (1/--lM) to inhibit the intracellular Ca 2 +-ATPase (54) , affected the BzATP-induced [Ca"], increase (Fig. 2C ) . However, both the conditions impairing the availability of intracellular calcium significantly reduced the ATP-evoked [Ca"], increase by about 30% and 42% respectively, indicating that the effect elicited by 2 mM ATP was at least partly dependent on the activation of the metabotropic ATP receptors (Fig. 2D ).
<-529 bp
Effect ofBzATP on Fura-2 e.fjlux Since P2X 7 ionotropic sites have been reported to form pores permeable to molecules up to 900 Da in different cell types (20, 56) (Fig. 3) , confirming that the activation of P2X 7 ionotropic receptors resulted in an influx of calcium in astrocytes.
Cysteinyl leukotriene efflux from rat brain astrocytes
Under resting conditions, the astrocytes released cysteinyl leukotrienes (CysLTs), 186 ± 29 pg/mg protein over a period of 30 min before stimulation (the establishedcollectiontime). The stimulationwas carried out for 30 min with the calcium ionophore A23187 (10 j..lM), Under these conditions, the efflux of CysLTs increased by about 3.5 fold over the basal values (639 ± 75 pg/mg protein) as shown in Fig. 4 . The efflux of extracellularCysLTs returned to near the basal values in the 60 min following the applied stimulation. In cells pretreated with 2 mM EGTA for 15 min, A23187 was unable to induce the biosynthetic release of CysLTs from the astrocytes (164 ± 34 pgimg protein. A similar result (235 ± 32 pgimg protein) was obtained when astrocyteswere pre-treatedfor 30 min with MK-886 (10 uM), a specific inhibitor of 5' -lipoxygenase-activating protein (FLAP) (55) (Fig. 4 inset) .
Effect ofP2X 7 activation on cysteynilleukotriene efflux from rat brain astrocytes
The addition of BzATP, up to 200 u M for 30 min, to the astrocytes induced a concentration-dependent increase in CysLT efflux (Fig. 5A) . The EC50 of BzATP in these experiments was 42 uM. The plateau of CysLT release was already reached at 100 u M BzATP,and this concentration was used in the further experiments. As shown in Fig. 5B , in the presence of 2 mM EGTA the P2X 7 agonist was unable to evoke the efflux of CysLTs from the cultured astrocytes. When astrocytes were pre-incubated for 2 hrs with the P2X 7 antagonist, oATP, the CysLT effux induced by BzATP was significantly reduced (Fig. 5B) . We recently reported that astrocytes have CysLT1 receptors, whereas CysLT 2 sites are lacking (12) . Cell pretreatment for 30 min with Cys-LTl receptor antagonists MK-571 (l u M) (25) did not modify BzATP-mediated effect (Fig. 5B) whereas cell pretreatment for 30 min with MK-886 (10 u M) abolished it (Fig. 5B ). We showed previously (5) that astrocytes express a variety of membrane transporters belonging to the ATP-binding cassette superfamily (ABC-proteins), including the multidrug-resistance-associated protein-l (Mrp 1) which seems to be the main responsible for the efflux of CysLTs (l0). Pretreatment of astrocytes for 60 min with a cocktail of ABC transporter inhibitors of(100 u.M glibenclamide 10pMA23187 Fig. 4. Effect ofA23187 (10 11M) (Fig. 5B ).
Effect of P2X 7 activation on 5-lipoxygenase and S-lipoxygenase activating protein (FLAP)
Northern blot assay was carried out to analyze the effect of 100 11M BzATP on the expression of 5-LO and FLAP transcripts in rat brain astrocytes. Constitutive expression of both 5-LO and FLAP mRNAs was observed ( Fig. 6A and  B) . The bands were normalized to GAPDH to account for differences in loading, and the increases in 5-LO and FLAP mRNA were expressed relative to their appropriate controls. Densitometric scanning showed that FLAP mRNA levels increased by about 2.5 fold in response to astrocyte treatment with 100 11M BzATP for 30 min, a period of time sufficient to increase the CysLT efflux from these cells, whereas 5-LO mRNA levels were not affected. As expected astrocyte pre-treatment for 2 hours with oATP (300 11M) abolished this effect (data not shown).
DISCUSSION
CysLTs are potent lipid mediators of inflammation. They have been extensively studied as mediators in the pathobiologic processes of allergic asthma and other respiratory disorders, but little is known on their role and cellular source in the CNS. However, CysLTs levels have been reported to increase in brain injuries, including cerebral ischemia, hemorrhage and epileptic seizures (14, 50) . Recently we reported that astrocytes and microglia release CysLTs both under resting conditions and following stimulation with the calcium ionophore A23187 or with ATP through P2Y 1 metabotropic receptor subtypes (12, 3) .
We focused our attention on the possible role of astrocyte P2X 7 ATP-ionotropic receptors in modulating the efflux of CysLTs, because high concentrations of the extracellular ATP, sufficient to activate P2X 7 receptors are reached under CNS pathological conditions (46, 29) in which the CysLT release has also been reported to increase. The activation of P2X 7 microglia is known to trigger the release of proinflammatory agents (42, 48, 39) , whereas less is known about the P2X 7-mediated effects in astroglial cells. Astrocytes are the major glial cell types and recent evidence indicate that they playa role in the modulation of inflammatory as well as in immune processes in CNS (16) (17) . Reverse transcription (RT)-PCR using specific primers, revealed the presence of P2X 7 receptor transcript in our cultured astrocytes. The receptors are functionally active since their activation by either ATP or the selective agonist BzATP increased [Ca 2 + h that was blocked by the oATP a specific P2X 7 antagonist. Consistent with the evidence that extracellular Ca 2 + mainly contributes to the P2X 7mediated [Ca 2 + hrise (6) we showed that this increase was unmodified by cell pretreatment with either PMA, to inhibit IPs formation, or with thapsigargin to cause Ca 2 + discharge from intracellular pools. The removal of extracellular calcium completely abolished the P2X 7-induced [Ca"]! increase in astrocyte suspensions (data not shown).
The changes in [Ca 2+]i induced by BzATP could reflect Ca 2 + binding to Fura-2 in both the intracellular and extracellular milieu since activated P2X 7 receptors form channels/pores permeable to molecules up to 900 Da (52) in immune cells. In our cultured astrocytes, BzATP did not cause Fura2 efflux suggesting that the P2X 7 forming pores do not seem to reach a size sufficient to allow this polyanion (636 Da) to exit the cells. Recently, Kim et al (2001) (28) reported that native P2X 7 receptors in peritoneal macrophages and bone marrow cells exist as highly bound multimeric complexes, whereas P2X 7 in brain glia seem to be only present as monomeric subunits.
In several cell types including macrophages, leukemia cells, eosinophils and microglia, the intracellular calcium rise play a key role in the biosynthetic production ofleukotrienes (2) (3) 57) .
In our cultured astrocytes, the calcium ionophore A23l87 induced the CysLTs release that was blocked by EGTA. P2X 7 receptors that increase the influx of calcium in astrocytes are also involved in rising CysLTs release. Indeed, BzATP induced a dosedependent increase in CysLT release that was blocked both by the P2X 7 antagonist o-ATP and by EGTA cell pretreatment. These data support the hypothesis that, besides P2Y metabotropic receptors (12) , also P2X 7 ionotropic sites are involved in the important role that astrocytes seem to exert in neuroinflammatory processes (45) . Moreover, it seems interesting to mention that the concentrations of CysLTs released under stimulation are in a range able to stimulate, in an autocrine manner, the CysLT receptors present in these cells. Upon activation astrocyte CysLT receptors could trigger, as we recently reported, different important effects including increase in cell proliferation and glial fibrillary acidic protein content (14) , thus participating in the reactive astrogliosis which represents a glial response to nearly every type of CNS injury.
We recently reported that in rat microglial cells the activation of CysLT liLT2 and P2Y I receptors increased the efflux of CysLTs. The P2Y I and CysLT liLT2 antagonists only blocked the efflux induced by the respective receptors, suggesting that the CysLT release is specifically and independently controlled by the two receptor types (3) . Analogously, in rat brain cultured astrocytes, which express P2X 7 and CysLT I receptor subtypes (12) , the specific CysLTI receptor antagonist did not affect the P2X 7 - It is known that in other cell types the biosynthetic release of CysLTs is mainly mediated by MRPI, a member ofthe family ofATP-binding cassette (ABC) proteins (l0). We previously showed that either rat brain cultured microglia or astrocytes express functional subtypes ofABC proteins including MRP 1 (4) . As expected the ABC-protein inhibitor cocktail significantly reduced the P2X 7-mediated efflux of CysLTs as it reduced the P2Y I-mediated CysLT release in microglia (3) .
The conversion of free arachidonic acid to leukotrienes is controlled by the key soluble enzyme 5-LO, however leukotriene synthesis does not occur in intact cells unless also FLAP, an integral membrane protein, is present (19) . FLAP seems to act as arachidonic acid transfer protein for 5-LO and to increase the efficiency of 5-LO conversion of 5hydroperoxyeicosatetraenoic acid (34, 1) . Both proteins are constitutively expressed in our cultured rat brain astrocytes as shown by Northern blot analysis and the FLAP inhibition by MK-886 abolished the robust CysLTs production induced by either A23I87 or BzATP.
In immune cells, FLAP mRNA levels have been reported to be induced by different kinds of stimuli including IL-3, granulocyte-monocyte colony stimulating factor, and TNF-a (7, 40, 44) . Northern blots analysis demonstrate that, in astrocytes, the activation of P2X 7 receptors is able to up-regulate FLAP mRNA without modifying that of 5-LO. This behavior is not surprising because, although some similarities exist between the promoter regions of 5-LO and FLAP genes, the former has the characteristic of a housekeeping gene and it has been reported that these two genes do not necessarily follow the same pattern of expression or regulation when studied in the same cell type (41, 26) . Interestingly, this first evidence of the P2X 7 capability to upregulate an important protein of leukotriene biosynthesis in astrocytes is consistent with the reported P2X 7 capability to increase the expression and/or the production of different proinflammatory mediators in astrocytes and astrocytoma cells (38, 58, 23) .
This study provides eviderice for the involvement ofP2X 7ATP-ionotropic receptors in the control of the efflux of CysLTs from astrocytes through the rise of intracellular calcium which is known to cooperate in the activation of the CysLT biosynthetic production. Moreover, the up-regulation of FLAP mRNA would favor the efficiency of the biosynthetic process thus contributing to the increase of CysLT release triggered by the P2X 7 stimulation.
In conclusion, the involvement of both metabotropic P2Y 1and ionotropic P2X 7 receptors in the regulation of CysLT biosynthetic release suggests a role for extracellular ARP as integral component of the inflammatory brain response. Although the role and the signalling pathways downstream P2X 7 activation in astrocytes have to be better studied, the modulation of astrocytes P2X 7 receptor activity as well as its expression could provide an interesting possibility in the treatment of inflammatory or degenerative CNS disorders.
